Long-term (5-year) antibody persistence following two- and three-dose regimens of a combined hepatitis A and B vaccine in children aged 1-11 years

Vaccine

Volumn 28, Issue 27, 2010, Pages 4411-4415

  Marshall, Helen ^a   Nolan, Terry ^b   Díez Domingo, Javier ^c   Rombo, Lars ^d,e   Sokal, Etienne M ^f   Marès, Josep ^g   Casanovas, Josep M ^h   Kuriyakose, Sherine ⁱ   Leyssen, Maarten ^j   Jacquet, Jeanne Marie ^j  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^d Center for Clinical Research Sormland County Council   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^g Mares Riera Paediatric Institute   (Spain)

^h INSTITUT CATALÀ DE LA SALUT   (Spain)

ⁱ GlaxoSmithKline Pharmaceuticals Ltd   (India)

^j GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

more..

Author keywords

Combined; Hepatitis; Paediatric

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A HEPATITIS B VACCINE; HEPATITIS B SURFACE ANTIBODY;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG DOSE REGIMEN; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEPATITIS A; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFANT; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYNCOPE; VACCINATION; VIRUS IMMUNITY;

CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A VACCINES; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INFANT; MALE; VACCINES, COMBINED;

EID: 77953124305     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.040     Document Type: Article

References (22)

1. World Hep Alliance, Hepatitis B and C. Available from: http://www.worldhepatitisday.com/HepatitisBandC.aspx. Cited on 14 April 2009.
2. World Health Organization (WHO). Dept. of Communicable diseases surveillance and Response. WHO/CDC/CSR/LYO/2002.2: Hepatitis B. Available from: http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf. Cited on 14 April 2009.
3. World Health Organization (WHO). WHO position paper, Hep A. Week Epidemiol Rec 75 (2000) 37-44
4. World Health Organization (WHO). WHO position paper Hep B. Week Epidemiol Rec 79 (2004) 253-264
5. Van Der Wielen M., Van Damme P., and Collard F. A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years. Pediatr Infect Dis J 19 9 (2000) 848-853
6. European Centre for Disease Control and Prevention, eCDC. Available from: http://ecdc.europa.eu/en/Health_Topics/hepatitis/hepatitisA/aer_07.aspx. Cited on 14 April 2009.
7. European Centre for Disease Control and Prevention, eCDC. Available from: http://ecdc.europa.eu/en/Health_topics/hepatitis/. Cited on 14 April 2009.
8. Van Damme P., Mathei C., Thoelen S., Meheus A., Safary A., and Andre F.E. Single dose inactivated hepatitis A vaccine: rationale and-clinical assessment of the safety and immunogenicity. J Med Virol 44 (1994) 435-441
9. Safary A., and Andre F. Over a decade of experience with a yeast recombinant hepatitis B. Vaccine 18 (2000) 57-67
10. Van Damme P., and Van Herck K. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis 5 (2007) 79-84
11. Thoelen S., Van Damme P., Leentvaar-Kuypers A., Leroux-Roels G., Bruguera M., Frei P.C., et al. The first combined vaccine against hepatitis A and B: an overview. Vaccine 17 (1999) 1657-1662
12. Van Damme P., Leroux-Roels G., Law B., Diaz-Mitoma F., Desombere I., Collard F., et al. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol 65 (2001) 6-13
13. Van Herck K., Leroux-Roels G., Van Damme P., Srinivasa K., and Hoet B. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix™) in adults. Travel Med Infect Dis 5 (2007) 171-175
14. Levie K., Beran J., Collard F., and Nguyen C. Long term (24 months) follow-up of a hepatitis A and B vaccine, comparing a two and three dose schedule in adolescents aged 12-15 years. Vaccine 20 (2002) 2579-2584
15. Hewlett A.T. Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis. Expert Opin Biol Ther 9 (2009) 1-6
16. Roberton D., Marshall H., Nolan T.M., Sokal E., Diez-Domingo J., and Flodmark E. Reactogenicity and immunogenicity profile of a two-dose combined hepatitis A and B vaccine in 1-11-year-old children. Vaccine 23 (2005) 5099-5105
17. Cambron P., Jacquet J.M., Hoet B., and Lievens M. Development and technical and clinical validation of a quantitative enzyme-linked immunosorbent assay for the detection of human antibodies to hepatitis B surface antigen in recipients of recombinant hepatitis B virus vaccine. Clin Vac Immunol 16 8 (2009) 1236-1246
18. Burgess M., and Rodger A. Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine Twinrix™ in healthy adolescent volunteers an open randomised study. Vaccine 19 32 (2001) 4835-4841
19. Duval B., Gîlca V., Boulianne N., De Wals P., Massé R., Trudeau G., et al. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country. Pediatr Infect Dis J 24 3 (2005) 213-218
20. Rendi-Wagner P., Korinek M., Winkler B., Kundi M., Kollaritsch H., and Wiedermann U. Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine 25 5 (2007) 927-931
21. Gabbuti A., Romano L., Blanc P., Meacci F., Amendolab A., Melec A., et al. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents. Vaccine 25 (2007) 3129-3132
22. Zanetti A.R., Mariano A., Romano L., D'Amelio R., Chironna M., Coppola R.C., et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 366 (2005) 1379-1384